MedPath

Evaluation of a Peer-Led Self-Management Programme (PLSMP) for people with schizophrenia

Completed
Conditions
Psychiatry/schizophrenia/rehabilitation
Mental and Behavioural Disorders
Schizophrenia
Registration Number
ISRCTN08387324
Lead Sponsor
ational University of Singapore (Singapore)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
242
Inclusion Criteria

This study aims to sample the whole population at the six centres (Simei Care Centre (SCC), Hougang Care Centre (HCC), Community Rehabilitation Support & Service (CRSS) and three Occupational Therapy: Activities, Vocation and Empowerment (OcTAVE) day centres) who meets the sample inclusion criteria during one-year recruitment period. This study will include participants who are:
1. Diagnosed with schizophrenia or schizoaffective disorders by a clinical psychiatrist according to DSM-IV or ICD-10
2. In a stable condition, not in acute mental health crisis or psychotic episode, and not been admitted to hospital due to relapse of schizophrenia symptom in the past 6 months, and no change in antipsychotic dosage in the past 6 months
3. Global Assessment of Functioning score more than 50
4. English speaking
5. 21-65 years old

Exclusion Criteria

Potential participants will be excluded if they have:
1. Non-related diagnosis, or having co-morbidity of personality disorders or mental retardation
2. Exposed to other PLSMP previously
3. Incompetent to sign informed consent as assessed by psychiatrist
In the event that participants are readmitted into a psychiatric hospital during the intervention period, their participation in the study will cease. If participants are readmitted to psychiatric hospital during the 12-month follow up period and be discharged before the 12-month follow up assessment, they will need re-assessment by their attending psychiatrist using Global Assessment of Functioning (GAF) to determine their competency in continuing with this study (GAF score of 50 and above). If participants are readmitted at 12-month assessment time, their participation will cease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath